BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37614615)

  • 1. The effects of
    Samii B; Jafarian A; Rabbani M; Zolfaghari B; Rahgozar S; Pouraboutaleb E
    Res Pharm Sci; 2023; 18(4):381-391. PubMed ID: 37614615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of methotrexate sensitivity in human leukemia cell lines by an adenosine triphosphate bioluminescence assay.
    Pinzani P; Carotti S; Gerli A; Pazzagli M; Mazzei T; Mini E
    Anticancer Drugs; 1997 Sep; 8(8):767-77. PubMed ID: 9396621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution properties of targacanthin (water-soluble part of gum tragacanth exudate from Astragalus gossypinus).
    Mohammadifar MA; Musavi SM; Kiumarsi A; Williams PA
    Int J Biol Macromol; 2006 Feb; 38(1):31-9. PubMed ID: 16469374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines.
    McCloskey DE; McGuire JJ; Russell CA; Rowan BG; Bertino JR; Pizzorno G; Mini E
    J Biol Chem; 1991 Apr; 266(10):6181-7. PubMed ID: 2007575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of IGF-I and cell density on MDR1 expression in the T-lymphoblastoid cell line CCRF-CEM.
    Schwarze CP; Neu S; Beck J; Mavridou K; Ranke MB; Binder G
    Horm Res; 1999; 52(4):192-9. PubMed ID: 10725785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxypeptidase G2 enhances trimetrexate cytotoxicity in CCRF-CEM cell lines sensitive and resistant to methotrexate.
    Romanini A; Chou TC; Bertino JR
    Adv Enzyme Regul; 1989; 28():323-33. PubMed ID: 2533849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E; Moroson BA; Franco CT; Bertino JR
    Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines.
    Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G
    Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
    Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
    Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Effect of Resveratrol and Prednisolone on MDR1 Protein Expression in Acute Lymphoblastic Leukemia Cell Line (CCRF-CEM).
    Talebi M; Bahar Aghdam S; Azimi A; Mohammadi H; Karimi Yonjali S; Asariha M; Zadi Heydarabad M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1171-1176. PubMed ID: 31030491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
    Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E
    Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.
    Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR
    Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.
    Zadi Heydarabad M; Nikasa M; Vatanmakanian M; Azimi A; Farshdousti Hagh M
    J Cell Biochem; 2018 Jun; 119(6):4890-4896. PubMed ID: 29377275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate.
    Norris MD; De Graaf D; Haber M; Kavallaris M; Madafiglio J; Gilbert J; Kwan E; Stewart BW; Mechetner EB; Gudkov AV; Roninson IB
    Int J Cancer; 1996 Mar; 65(5):613-9. PubMed ID: 8598312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.